Russia's EpiVacCorona vaccine has 100% efficacy, says report

19-01-2021

The immunological efficacy of the Russia-developed coronavirus vaccine EpiVacCorona is 100 per cent, Sputnik News quoted the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being as saying. EpiVacCorona is a coronavirus vaccine developed by the Vektor State Research Center of Virology and Biotechnology in Russia. The mass trials of EpiVacCorona has begun in Russia in November. The peptide-based vaccine is the second to be licensed for use in Russia. Moscow has said its other approved Covid-19 vaccine, Sputnik V, is 92 per cent effective at protecting people from Covid-19 according to interim results.